Rice et al. 2020
Featured Short Report: Contribution of GABAergic interneurons to amyloid-β plaque pathology in an APP knock-in mouse model
Heather C. Rice, …, Bart De Strooper
Chen et al. 2020
Featured Research: Promoting tau secretion and propagation by hyperactive p300/CBP via autophagy-lysosomal pathway in tauopathy
Xu Chen, …, Ana Maria Cuervo and Li Gan
An et al. 2019
Featured Research: Longitudinal and nonlinear relations of dietary and Serum cholesterol in midlife with cognitive decline: results from EMCOA study
Yu An, Xiaona Zhang, …, Zhongsheng Qin and Rong Xiao
Pandey et al. 2019
Featured Research: Genetic perturbations of disease risk genes in mice capture transcriptomic signatures of late-onset Alzheimer’s disease
Ravi S. Pandey, …, Gareth R. Howell and Gregory W. Carter
Articles
-
-
Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment
-
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
-
Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers
-
A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles
-
Exosomal cell-to-cell transmission of alpha synuclein oligomers
-
Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1polymorphisms
-
Drosophila melanogaster as a model organism for Alzheimer’s disease
-
The Alzheimer's disease β-secretase enzyme, BACE1
-
The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
Editor highlights
Register now for ICMN2020
The 6th International Conference on Molecular Neurodegeneration will focus on Glial and Vascular Contributions to Neurodegenerative Diseases.
The deadline for ICMN2020's travel grant application and abstract submission has been extended to February 7.
Join us in Bangkok, Thailand on May 21-23 2020!
About | Program | Registration
Parkinson's disease - a series of reviews
Molecular Neurodegeneration presents a new thematic series, collating reviews on recent advances in Parkinson's Disease research.
Guest Edited by Mark Cookson and Ted Dawson, reviews will continue to publish throughout 2020. The collection can be read here.
About Us
The leading open access journal in the field of neurosciences, Molecular Neurodegeneration encompasses all aspects of neurodegeneration research at the molecular and cellular levels.
Editors-in-Chief:
- Guojun Bu, Mayo Clinic, USA
- Huaxi Xu, Sanford Burnham Prebys Medical Discovery Institute, USA
Advertisement
Follow
Editors-in-Chief
Guojun Bu, Mayo Clinic, USA
Huaxi Xu, Sanford Burnham Prebys Medical Discovery Institute, USA
Annual Journal Metrics
-
Speed
45 days to first decision for reviewed manuscripts only
32 days to first decision for all manuscripts
139 days from submission to acceptance
15 days from acceptance to publication
Citation Impact
8.274 - 2-year Impact Factor
8.102 - 5-year Impact Factor
1.436 - Source Normalized Impact per Paper (SNIP)
3.988 - SCImago Journal Rank (SJR)
Usage
460,499 downloads
494 Altmetric mentions
Advertisement
